Paper33333383
Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer.
Hao J and 3 others. J Surg Res, 2021. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer. Papers, record 33333383. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33333383
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Breast Neoplasms | Major topic |
| Doxorubicin | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | Major topic |
| MicroRNAs | Major topic |
| RNA, Circular | Major topic |
| Animals | |
| Biomarkers, Tumor | |
| Blotting, Western | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cell Proliferation | |
| Down-Regulation | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Gene Knockdown Techniques | |
| Humans | |
| Mice, Nude | |
| Neoplasm Invasiveness | |
| Neoplasm Transplantation | |
| Real-Time Polymerase Chain Reaction | |
| Up-Regulation | |
| Mice |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41479116 | The Transcriptional Role of Circular RNAs in Drug Resistance by Modulating the miRNA/mRNA Axis. | Exp Suppl | 2026 | https://conductscience.org/library/papers/41479116 | PubMed |
| 41009512 | Exploratory Analysis of Circulating Serum miR-197-3p, miR-1236, and miR-1271 Expression in Early Breast Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009512 | PubMed |
| 40328911 | circRNA/TLR interaction: key players in immune regulation and autoimmune diseases. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40328911 | PubMed |
| 40080898 | Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance. | Technol Cancer Res Treat | 2025 | https://conductscience.org/library/papers/40080898 | PubMed |
| 39614315 | The role of circRNAs in resistance to doxorubicin. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/39614315 | PubMed |
| 39267922 | The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer. | Cancer Drug Resist | 2024 | https://conductscience.org/library/papers/39267922 | PubMed |
| 39006913 | Screening of a Prognostic Gene Signature for Relapsed/Refractory Acute Myeloid Leukemia Based on Altered Circulating CircRNA Profiles. | Int J Gen Med | 2024 | https://conductscience.org/library/papers/39006913 | PubMed |
| 38730434 | CircPRELID2 functions as a promoter of renal cell carcinoma through the miR-22-3p/ETV1 cascade. | BMC Urol | 2024 | https://conductscience.org/library/papers/38730434 | PubMed |
| 38671354 | Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective. | Cell Mol Biol Lett | 2024 | https://conductscience.org/library/papers/38671354 | PubMed |
| 38367868 | The therapeutic potential of targeting the CHD protein family in cancer. | Pharmacol Ther | 2024 | https://conductscience.org/library/papers/38367868 | PubMed |
| 38282696 | Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer. | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/38282696 | PubMed |
| 37882644 | Circular RNAs: biology and clinical significance of breast cancer. | RNA Biol | 2023 | https://conductscience.org/library/papers/37882644 | PubMed |
| 37736901 | Novel Insights into Circular RNAs in Metastasis in Breast Cancer: An Update. | Noncoding RNA | 2023 | https://conductscience.org/library/papers/37736901 | PubMed |
| 37550533 | Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role. | Med Oncol | 2023 | https://conductscience.org/library/papers/37550533 | PubMed |
| 37304411 | circRNAs in drug resistance of breast cancer. | Oncol Res | 2022 | https://conductscience.org/library/papers/37304411 | PubMed |
| 37175555 | Mutual Regulation of ncRNAs and Chromatin Remodeling Complexes in Normal and Pathological Conditions. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175555 | PubMed |
| 37093684 | Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical In Vivo Models. | Cancer Genomics Proteomics | 2023 | https://conductscience.org/library/papers/37093684 | PubMed |
| 36622564 | Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer. | Breast Cancer | 2023 | https://conductscience.org/library/papers/36622564 | PubMed |
| 36539545 | Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta‑analysis. | Sci Rep | 2022 | https://conductscience.org/library/papers/36539545 | PubMed |
| 36132137 | The role of CircRNA/miRNA/mRNA axis in breast cancer drug resistance. | Front Oncol | 2022 | https://conductscience.org/library/papers/36132137 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CHD4 | 1108 | PubTator's text mining | https://conductscience.org/library/genes/1108 | NCBI Gene |
| MIR1236 | 100302242 | PubTator's text mining | https://conductscience.org/library/genes/100302242 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33333383
GET https://conductscience.org/api/papers/v1/33333383/cited_by?page=2